| Crystal structure of human 20alpha-HSD in ternary complex with NADP and 20alpha-hydroxy-progesterone | | monomer | 2-323 | 100 | 1×NAP; 1×STR; 1×BME; |
|
| Crystal structure of AKR1C1 in complex with NADP and 3,5-dichlorosalicylic acid | | monomer | 4-323 | 100 | 1×ZN; 1×NAP; 1×C2U; |
|
| Crystal structure of AKR1C1 in complex with DFV | | monomer | 4-323 | 100 | 1×NAP; 1×DFV; |
|
| Crystal structure of AKR1C1 in complex with NADP and 5-Phenyl,3-chlorosalicylic acid | | monomer | 6-323 | 100 | 1×NAP; 1×5P3; 1×ZN; |
|
| Crystal structure of AKR1C1 L308V mutant in complex with NADP and 3,5-dichlorosalicylic acid | | monomer | 6-323 | 99.69 | 1×NAP; 1×C2U; 1×ZN; |
|
| Crystal Structure of AKR1C1 complexed with meclofenamic acid | | monomer | 6-323 | 100 | 1×NAP; 1×JMS; |
|
| AKR1C1 complexed with new inhibitor with novel scaffold | | monomer | 6-323 | 100 | 1×NAP; 1×9S0; |
|
| Crystal Structure of AKR1C1 complexed with glibenclamide | | monomer | 6-323 | 100 | 1×NAP; 1×GBM; |
|